Delivery Order SPE2DB22D2206-SPE2DB25FEY67

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $72K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $85,984.81, is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,995.09 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of October 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,327.82 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30 tablets. The contract has an ultimate completion date of November 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,660.62 Firm Fixed Price Delivery Order covers the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This award is associated with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,545.46 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of June 11, 2024 and was awarded on June 10, 2024. This award is a part of AmerisourceBergen's $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,489.32 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of June 14, 2024 and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $27,268.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a specialty pharmaceutical product, with a period of performance through February 26, 2024. The contract is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,382.83 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30s. The contract has an ultimate completion date of July 25, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,442.34 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product, with a completion date of December 16, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,652.51, is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a specialty pharmaceutical product. The contract appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEY67
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $71,731.29, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of January 6, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There was no set-aside designation for this specific contract award.

Generated 4/4/25, 10:42 AM